BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Watanabe R, Berry GJ, Liang DH, Goronzy JJ, Weyand CM. Pathogenesis of Giant Cell Arteritis and Takayasu Arteritis-Similarities and Differences. Curr Rheumatol Rep 2020;22:68. [PMID: 32845392 DOI: 10.1007/s11926-020-00948-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 29] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Kadian-Dodov D, Seo P, Robson PM, Fayad ZA, Olin JW. Inflammatory Diseases of the Aorta: JACC Focus Seminar, Part 2. J Am Coll Cardiol 2022;80:832-44. [PMID: 35981827 DOI: 10.1016/j.jacc.2022.05.046] [Reference Citation Analysis]
2 Watanabe R, Hashimoto M. Pathogenic role of monocytes/macrophages in large vessel vasculitis. Front Immunol 2022;13:859502. [DOI: 10.3389/fimmu.2022.859502] [Reference Citation Analysis]
3 Gonzalez Chiappe S, Lechtman S, Maldini CS, Mekinian A, Papo T, Sené T, Mahr AD. Incidence of giant cell arteritis in six districts of Paris, France (2015-2017). Rheumatol Int 2022. [PMID: 35819504 DOI: 10.1007/s00296-022-05167-4] [Reference Citation Analysis]
4 Watanabe R, Hashimoto M. Vasculitogenic T Cells in Large Vessel Vasculitis. Front Immunol 2022;13:923582. [DOI: 10.3389/fimmu.2022.923582] [Reference Citation Analysis]
5 Chen J, Gu L, Zhou Y, Li T, Ye S. Inflammation, new bone formation and aorta. Int J Rheum Dis 2022. [PMID: 35694775 DOI: 10.1111/1756-185X.14366] [Reference Citation Analysis]
6 Watanabe R, Hashimoto M. Perspectives of JAK Inhibitors for Large Vessel Vasculitis. Front Immunol 2022;13:881705. [PMID: 35432355 DOI: 10.3389/fimmu.2022.881705] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
7 Watanabe R, Hashimoto M. Aging-Related Vascular Inflammation: Giant Cell Arteritis and Neurological Disorders. Front Aging Neurosci 2022;14:843305. [DOI: 10.3389/fnagi.2022.843305] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Azzam O, Hubble D, Prentice D. Cough as a clinical manifestation of large vessel vasculitis. Internal Medicine Journal 2022;52:488-90. [DOI: 10.1111/imj.15710] [Reference Citation Analysis]
9 Dhanani U, Zhao MY, Charoenkijkajorn C, Pakravan M, Mortensen PW, Lee AG. Large-Vessel Vasculitis in Ophthalmology: Giant Cell Arteritis and Takayasu Arteritis. Asia Pac J Ophthalmol (Phila) 2022;11:177-83. [PMID: 35533336 DOI: 10.1097/APO.0000000000000514] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Jin K, Parreau S, Warrington KJ, Koster MJ, Berry GJ, Goronzy JJ, Weyand CM. Regulatory T Cells in Autoimmune Vasculitis. Front Immunol 2022;13:844300. [DOI: 10.3389/fimmu.2022.844300] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
11 Jiang W, Sun M, Wang Y, Zheng M, Yuan Z, Mai S, Zhang X, Tang L, Liu X, Wang C, Wen Z. Critical Role of Notch-1 in Mechanistic Target of Rapamycin Hyperactivity and Vascular Inflammation in Patients With Takayasu Arteritis. Arthritis Rheumatol 2022. [PMID: 35212196 DOI: 10.1002/art.42103] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Gloor AD, Berry GJ, Goronzy JJ, Weyand CM. Age as a risk factor in vasculitis. Semin Immunopathol 2022. [PMID: 35141865 DOI: 10.1007/s00281-022-00911-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
13 Kim S, Ahn S, Lee HS, Lee W, Moon J, Park JK, Chu K. Direct brain involvement of Takayasu arteritis treated with rituximab and infliximab: a case report. encephalitis 2022;2:9-13. [DOI: 10.47936/encephalitis.2021.00108] [Reference Citation Analysis]
14 Besutti G, Muratore F, Mancuso P, Ferrari M, Galli E, Spaggiari L, Monelli F, Casali M, Versari A, Boiardi L, Marvisi C, Ligabue G, Pattacini P, Giorgi Rossi P, Salvarani C. Vessel inflammation and morphological changes in patients with large vessel vasculitis: a retrospective study. RMD Open 2022;8:e001977. [PMID: 34987095 DOI: 10.1136/rmdopen-2021-001977] [Reference Citation Analysis]
15 Pugh D, Karabayas M, Basu N, Cid MC, Goel R, Goodyear CS, Grayson PC, McAdoo SP, Mason JC, Owen C, Weyand CM, Youngstein T, Dhaun N. Large-vessel vasculitis. Nat Rev Dis Primers 2022;7:93. [PMID: 34992251 DOI: 10.1038/s41572-021-00327-5] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
16 Stojanovic M, Raskovic S, Milivojevic V, Miskovic R, Soldatovic I, Stankovic S, Rankovic I, Stankovic Stanojevic M, Dragasevic S, Krstic M, Diamantopoulos AP. Enhanced Liver Fibrosis Score as a Biomarker for Vascular Damage Assessment in Patients with Takayasu Arteritis-A Pilot Study. J Cardiovasc Dev Dis 2021;8:187. [PMID: 34940542 DOI: 10.3390/jcdd8120187] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Biscetti L, De Vanna G, Cresta E, Corbelli I, Gaetani L, Cupini L, Calabresi P, Sarchielli P. Headache and immunological/autoimmune disorders: a comprehensive review of available epidemiological evidence with insights on potential underlying mechanisms. J Neuroinflammation 2021;18:259. [PMID: 34749743 DOI: 10.1186/s12974-021-02229-5] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
18 Solimando AG, Vacca A, Dammacco F. Highlights in clinical medicine-Giant cell arteritis, polymyalgia rheumatica and Takayasu's arteritis: pathogenic links and therapeutic implications. Clin Exp Med 2021. [PMID: 34741677 DOI: 10.1007/s10238-021-00770-4] [Reference Citation Analysis]
19 Ren YL, Li TT, Cui W, Zhao LM, Gao N, Liao H, Zhang JH, Zhu JM, Qiao ZY, Guo SC, Pan LL. CD8+ T lymphocyte is a main source of interferon-gamma production in Takayasu's arteritis. Sci Rep 2021;11:17111. [PMID: 34429489 DOI: 10.1038/s41598-021-96632-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Kaneko Y, Takeuchi T. An update on the pathogenic role of IL-6 in rheumatic diseases. Cytokine 2021;146:155645. [PMID: 34303949 DOI: 10.1016/j.cyto.2021.155645] [Reference Citation Analysis]
21 Jia S, Liu L, Ma J, Chen X. Application progress of multiple imaging modalities in Takayasu arteritis. Int J Cardiovasc Imaging 2021. [PMID: 34287748 DOI: 10.1007/s10554-021-02348-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Kadoba K, Watanabe R, Iwasaki T, Nakajima T, Kitagori K, Akizuki S, Murakami K, Nakashima R, Hashimoto M, Tanaka M, Ohmura K, Morinobu A, Terao C, Yoshifuji H. A susceptibility locus in the IL12B but not LILRA3 region is associated with vascular damage in Takayasu arteritis. Sci Rep 2021;11:13667. [PMID: 34211061 DOI: 10.1038/s41598-021-93213-9] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
23 Naraoka S, Uchiyama H, Yano T, Mikami T, Harada R, Kuroda Y, Toda Y, Muranaka A, Sugawara T, Hasegawa T, Miura T, Kawaharada N. Case Report: Disappearance of Coronary Anastomotic Aneurysm by Steroid Therapy in Takayasu Arteritis: Pseudorepair of Pseudoaneurysm? Front Cardiovasc Med 2021;8:683216. [PMID: 34150873 DOI: 10.3389/fcvm.2021.683216] [Reference Citation Analysis]
24 Clifford AH, Cohen Tervaert JW. Cardiovascular events and the role of accelerated atherosclerosis in systemic vasculitis. Atherosclerosis 2021;325:8-15. [PMID: 33873090 DOI: 10.1016/j.atherosclerosis.2021.03.032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Nienhuis PH, van Praagh GD, Glaudemans AWJM, Brouwer E, Slart RHJA. A Review on the Value of Imaging in Differentiating between Large Vessel Vasculitis and Atherosclerosis. J Pers Med 2021;11:236. [PMID: 33806941 DOI: 10.3390/jpm11030236] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
26 Reitsema RD, Boots AMH, van der Geest KSM, Sandovici M, Heeringa P, Brouwer E. CD8+ T Cells in GCA and GPA: Bystanders or Active Contributors? Front Immunol 2021;12:654109. [PMID: 33815414 DOI: 10.3389/fimmu.2021.654109] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Robinette ML, Rao DA, Monach PA. The Immunopathology of Giant Cell Arteritis Across Disease Spectra. Front Immunol 2021;12:623716. [PMID: 33717128 DOI: 10.3389/fimmu.2021.623716] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
28 Akiyama M, Ohtsuki S, Berry GJ, Liang DH, Goronzy JJ, Weyand CM. Innate and Adaptive Immunity in Giant Cell Arteritis. Front Immunol 2020;11:621098. [PMID: 33717054 DOI: 10.3389/fimmu.2020.621098] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
29 Kang K, Sun Y, Li YL, Chang B. Pathogenesis of liver injury in Takayasu arteritis: advanced understanding leads to new horizons. J Int Med Res 2020;48:300060520972222. [PMID: 33275473 DOI: 10.1177/0300060520972222] [Reference Citation Analysis]